"We partnered with Biomedical
Strategy Consultants initially to do some limited market sizing/
opportunity assessment work, but quickly realized that despite their
small size they are able to activate high quality, healthcare savvy
resources to not just do market analysis but help solve business
problems. We were so pleased with the quality of their work and
responsiveness that we have since asked them to help us sort out our
distribution strategy and do a more focused study on a key growing
market segment. We have now used them on four successive projects in two
different countries (China and India).
I’ve been particularly pleased by their strong customer focus. Rather
that worry about whether certain questions or problems are in scope on a
project, they have focused on helping us get the answers we need. Their
project organization skills are first class, and they have been able to
communicate effectively with different levels of our organization. I
believe they are so effective, because the team at Biomedical Strategy
Consultants is made up entirely of people with strong line management
experience in multi-national healthcare firms operating in Asia. In
their past, they have been in our position, so they know almost
intuitively what we want and how we want it done! "
Robert L. Larson
Development & Marketing Asia Pacific
"Biomedical Strategy Consultants listened to and understood our
business objectives, and sought to uncover key aspects of local market
dynamics with energy and focus. Their Japanese consultants added a level
of understanding of how the market operates which could only come from
business experience gained over many years of practice in that region.
The final report was presented in a very professional manner, and
summarized strategic options for growth based on newly acquired
information plus their considerable industry insights. Their analysis
and recommendations provided a well thought through choice of
alternative Japanese market development strategies."
Dr. Alastair Mcleod
Pressure Area Care
"We engaged Biomedical Strategy Consultants for a major
strategy development and opportunity assessment project in China. Their
industry network in Asia is very impressive and they were quickly able
to arrange face-to-face interviews in Mandarin with leading clinicians .
Biomedical Strategy Consultants provided invaluable market insights
and helped us gain an in-depth understanding of the dynamics of the
Chinese medical device market. The strategies and recommendations
developed through the project allowed us to present a meaningful plan of
action to our Board of Directors.
The team at Biomedical Strategy Consultants is extremely responsive
and has been a pleasure to work with. We highly recommend them and look
forward to working with them again on our future activities in
CFO & Vice President
Inovise Medical, Inc.
"Utah Medical Products, Inc. (UTMD) engaged Biomedical Strategy
Consultants to perform a distributor search for the Japanese medical
device market. From the onset, they treated their consultancy as a
business partnership, rather than simply a vendor–customer relationship.
The team at Biomedical Strategy Consultants seemed keenly aware that
listening to what UTMD wanted was extremely important to provide the
result UTMD was seeking.
UTMD was impressed with their knowledge of the Japanese medical
device market. It was apparent that both Fredrik Nyberg and Ray Tsunoda
had worked in and had many contacts within the Japanese market. They
went above and beyond the consulting agreement by not only successfully
completing the engagement but also identifying and supporting UTMD’s
efforts to secure other, peripheral opportunities.
UTMD recommends Biomedical Strategy Consultants to other medical
device companies seeking to penetrate the Japanese market."
Chief Financial Officer
"At the end of 2002 Syncor International was acquired by Cardinal
Health in a transaction that had a value of approximately US $900
million at the time of close. Cardinal Health made a decision to divest
both the Medical Imaging and International businesses of Syncor
International and I was asked, as the former President and CEO of Syncor
International to develop and implement a plan for the timely sale of
I engaged Biomedical Strategy Consultants to assist me and the
divestiture team in accomplishing a number of critical objectives:
Under Kin Chua’s leadership as interim manager, performance against
each of these objectives far exceeded my expectations and as a result
Cardinal Health was successful in completing the sale of these
businesses to new owners within a period of eight months."
Former President & CEO
International, Inc. (now a unit of Cardinal Health, Inc.)
"As a major Asian provider of CNC precision-machined components,
Spindex recently embarked on a project to explore diversification into
the medical device industry. Biomedical Strategy Consultants were of
great help in researching opportunities in the global market of
orthopaedic implants and instruments. They introduced us to high quality
prospective buyers in the industry and provided a detailed map of the
Their research, analysis and recommendations proved invaluable in
defining our entry strategy. The quality of their work was consistently
above our expectations. They are highly competent, professional and
responsive. I enjoyed working with Fredrik and his team and can
thoroughly recommend them to any contract manufacturer planning to enter
the biomedical industry.
Thanks for a job well done!"
Choo Heng Thong
Back to Top